苏泽特里金:一种新的选择性通道抑制剂,用于止痛
Denise Courtney1, Sudheer Potru2, Paige Mathew3
1Veterans Health Administration Southeast Network, Decatur, GA, USA.
概括
苏泽,一种新的口服止痛药,通过向Nav1.8道,有效地减少急性手术后疼痛. 它提供了一个非阿片类药物替代品,具有良好的安全性,并正在为其他类型的疼痛进行研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
- 神经学 神经学
背景情况:
- 电压控制的通道在疼痛信号传输中起着至关重要的作用.
- Nav1.8通道特别涉及到疼痛感知.
- 针对特定通道亚型的新型止痛药有可能改善疼痛管理.
研究的目的:
- 探索suzetrigine,一种新的电压门道抑制剂,用于疼痛管理.
- 评估suzetrigine在中度至重度急性疼痛患者中的疗效和安全性.
- 调查suzetrigine作为一种非阿片类药物替代品来管理各种疼痛条件的潜力.
主要方法:
- 进行了第三期疗效试验,以评估suzetrigine的有效性.
- 与安慰剂相比,suzetrigine的减轻疼痛功效的比较.
- 在临床试验中评估suzetrigine的安全性和耐受性概况.
主要成果:
- 在手术后减轻疼痛强度方面,苏泽特里金在统计学上显著地优于安慰剂.
- 这种药物在研究患者群体中一般耐受良好.
- 目前正在进行的研究正在探索suzetrigine用于非急性疼痛症状,如糖尿病外围神经病变和根性病变.
结论:
- 苏泽特里金是第一类口服外围通道抑制剂,向Nav1.8通道,已被批准用于急性疼痛.
- 它作为一种非阿片类药物疼痛管理选择,具有潜在较低的滥用风险和比阿片类药物更少的严重不良影响.
- 需要进一步的研究,以确定各种疼痛条件的长期安全性和有效性,并继续研究用于止痛的选择性外周通道抑制剂.
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
446
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
446
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.6K
01:08Antiepileptic Drugs: Sodium Channel Blockers
875
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
875
01:20Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.7K
01:26Voltage-gated Ion Channels
8.6K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.6K